383 — Tian An Medicare Income Statement
0.000.00%
Last trade - 00:00- HK$1.12bn
- HK$1.32bn
- HK$1.64bn
Annual income statement for Tian An Medicare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,463 | 1,438 | 1,569 | 1,627 | 1,638 |
| Cost of Revenue | |||||
| Gross Profit | 267 | 266 | 290 | 336 | 310 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,516 | 1,496 | 1,480 | 1,541 | 1,616 |
| Operating Profit | -52.2 | -58.2 | 88.6 | 86.1 | 21.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -110 | -117 | 40.8 | 57 | -0.469 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -127 | -119 | 25.9 | 42 | -20.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -137 | -124 | 14.7 | 28.8 | -26.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -137 | -124 | 14.7 | 28.8 | -26.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.158 | -0.173 | 0.017 | 0.035 | -0.024 |
| Dividends per Share |